NCT01597713: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects |
|
|
| Completed | 1 | 83 | Europe | NNC 0148-0000-0362, insulin glargine, placebo | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2, Healthy | 10/12 | 10/12 | | |
